Enovis targets $2.31-$2.37B 2026 revenue with 4-6% organic growth as margin expansion and innovation accelerate
Source: SeekingAlpha
2026-02-27 02:28:30 ET
More on Enovis Corporation
- Enovis Corporation (ENOV) Q4 2025 Earnings Call Transcript
- Enovis: Valuation Is Too Low, But Needs To Differentiate On Growth
- Enovis Corporation (ENOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Enovis Corporation Q4 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Enovis Corporation
Read the full article on Seeking Alpha
For further details see:
Enovis targets $2.31–$2.37B 2026 revenue with 4–6% organic growth as margin expansion and innovation accelerate
Enovis Corporation
NASDAQ: ENOV
ENOV Trading
-4.34% G/L:
$24.22 Last:
461,474 Volume:
$25.45 Open:
ENOV Latest News
February 26, 2026 05:00:27 pm
One Fund Bet $5 Million on Enovis Stock Last Quarter. Shares Surged 14% Post-Earnings
February 03, 2026 08:00:00 am
Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
ENOV Stock Data
$1,290,764,329
55,645,268
0.07%
99
N/A
Medical Equipment & Supplies
Healthcare
US
Wilmington
